Dow Up 0.11% Nasdaq Up 0.50%

Gilead Sciences Inc. (GILD)

-NasdaqGS
107.56 0.05(0.05%) Aug 29, 4:00PM EDT
|Pre-Market : 108.59 Up 1.03 (0.96%) 5:08AM EDT - Nasdaq Real Time Price
Prev Close:107.51
Open:108.00
Bid:108.60 x 100
Ask:109.26 x 500
1y Target Est:112.00
Beta:0.95
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:106.78 - 108.24
52wk Range:58.81 - 108.77
Volume:11,327,388
Avg Vol (3m):11,989,100
Market Cap:162.60B
P/E (ttm):39.84
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 0.05%162.60B
GSK117.94B
PFE186.36B
RHHBY248.08B

Key Statistics

Forward P/E (1 yr):11.50
P/S (ttm):9.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.00
Quarterly EPS Est (Sep-14) :1.89
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback